Your browser doesn't support javascript.
loading
X-CHIME enables combinatorial, inducible, lineage-specific and sequential knockout of genes in the immune system.
LaFleur, Martin W; Lemmen, Ashlyn M; Streeter, Ivy S L; Nguyen, Thao H; Milling, Lauren E; Derosia, Nicole M; Hoffman, Zachary M; Gillis, Jacob E; Tjokrosurjo, Qin; Markson, Samuel C; Huang, Amy Y; Anekal, Praju V; Montero Llopis, Paula; Haining, W Nicholas; Doench, John G; Sharpe, Arlene H.
Afiliação
  • LaFleur MW; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Lemmen AM; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Streeter ISL; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Nguyen TH; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Milling LE; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Derosia NM; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Hoffman ZM; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Gillis JE; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Tjokrosurjo Q; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Markson SC; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Huang AY; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Anekal PV; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Montero Llopis P; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Haining WN; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Doench JG; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Sharpe AH; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Nat Immunol ; 25(1): 178-188, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38012416
ABSTRACT
Annotation of immunologic gene function in vivo typically requires the generation of knockout mice, which is time consuming and low throughput. We previously developed CHimeric IMmune Editing (CHIME), a CRISPR-Cas9 bone marrow delivery system for constitutive, ubiquitous deletion of single genes. Here we describe X-CHIME, four new CHIME-based systems for modular and rapid interrogation of gene function combinatorially (C-CHIME), inducibly (I-CHIME), lineage-specifically (L-CHIME) or sequentially (S-CHIME). We use C-CHIME and S-CHIME to assess the consequences of combined deletion of Ptpn1 and Ptpn2, an embryonic lethal gene pair, in adult mice. We find that constitutive deletion of both PTPN1 and PTPN2 leads to bone marrow hypoplasia and lethality, while inducible deletion after immune development leads to enteritis and lethality. These findings demonstrate that X-CHIME can be used for rapid mechanistic evaluation of genes in distinct in vivo contexts and that PTPN1 and PTPN2 have some functional redundancy important for viability in adult mice.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Tirosina Fosfatase não Receptora Tipo 2 / Sistemas CRISPR-Cas Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Tirosina Fosfatase não Receptora Tipo 2 / Sistemas CRISPR-Cas Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article